glp 1 based therapies Rethinking GLP-1RA Therapy Through the Lens of Glucagon and Resilience The GLP-1 Revolution: How Next-Generation

doi: 10.1080/21641846.2014.978109 4 ValdezARHancockEEAdebayoSKiernickiDJProskauerDAttewellJRet al

Cunto tiempo puedo ver los resultados

[21] For patients undergoing surgery , the approach should be individualised based on several factors: Aspiration risk assessment : Patients with symptoms of gastroparesis, those on high doses, or those who have recently initiated therapy may have increased risk Type of surgery : Particularly procedures involving the gastrointestinal tract Indication for GLP-1 therapy : Whether for diabetes management or weight loss If GLP-1 medications are temporarily withheld based on individual risk assessment or local policy, patients with diabetes should have a clear plan for glycaemic management, including capillary glucose monitoring and potential bridging therapy, developed in consultation with the diabetes team

No direct causal link has been established between GLP-1R use and increased aspiration risk

Healthy inflammatory and antioxidant responses